|
|
|
Volumn 13, Issue 4, 2001, Pages 31-41
|
|
Anal neoplasia: a growing concern.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
VIRUS VACCINE;
ANUS TUMOR;
ARTICLE;
COST BENEFIT ANALYSIS;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HOMOSEXUALITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
RADIOTHERAPY;
RISK FACTOR;
UTERINE CERVIX TUMOR;
VIRUS INFECTION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
ANUS NEOPLASMS;
COMBINED MODALITY THERAPY;
COST-BENEFIT ANALYSIS;
FEMALE;
HIV INFECTIONS;
HOMOSEXUALITY, MALE;
HUMANS;
MALE;
PAPILLOMAVIRUS INFECTIONS;
RADIOTHERAPY;
RISK FACTORS;
UTERINE CERVICAL NEOPLASMS;
VIRAL VACCINES;
|
|
EID: 0035653419
PISSN: 1058708X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
